IDEXX experienced an impressive 2016. Forbes Magazine recognized IDEXX as one of the globe’s “most innovative” organizations, and as one of America’s most trustworthy companies. The International Renal Interest Society included our blockbuster kidney function test, SDMA, in its guidelines, and we launched a revolutionary new instrument and billing model with SediVue Dx.
As we turn to a new year, IDEXX kicked off 2017 with more exciting news. The American financial services company Standard and Poor’s announced the first week of January that IDEXX has made the S&P 500 stock market index for the first time—joining such global leaders as Apple, Microsoft, Amazon, and AT&T.
“It’s an incredible honor for IDEXX to be included in the S&P 500, alongside many of the world’s most respected companies,” said CEO Jon Ayers. “This recognition is testament to our growth since our founding in Portland, Maine, some 34 years ago. IDEXX is proud to add a company focused on pet health care technology to the S&P 500. I’m deeply grateful to all of our employees who helped us achieve this accomplishment.”
The Standard and Poor’s 500 is an American stock market index widely considered the best gauge of leading U.S. large-cap equities, with index assets totaling $2.2 trillion. You can read more about the S&P 500 on Investopedia—or see IDEXX’s recent local coverage on Maine’s WCSH.com.